Skip to main content
新赣江 logo

新赣江 — Investor Relations & Filings

Ticker · 920367 Beijing Stock Exchange Manufacturing
Open in API
Filings indexed 389 across all filing types
Latest filing 2024-07-28 Board/Management Inform…
Country CN China
Listing Beijing Stock Exchange 920367

About 新赣江

http://www.xgjyy.com/

Jiangxi Xinganjiang Pharmaceutical Co., Ltd. specializes in the research, development, production, and distribution of a diverse range of pharmaceutical products. The company's portfolio encompasses chemical active pharmaceutical ingredients (APIs), chemical drug preparations, and traditional Chinese medicine (TCM) formulations. Its core product offerings target therapeutic areas such as cardiovascular and cerebrovascular health, digestive system disorders, and nutritional supplementation. Key products include Ginkgo Biloba extract, Vitamin C, and various gastrointestinal medications. By maintaining an integrated value chain that spans from raw material synthesis to finished dosage forms, the company ensures quality control and supply chain efficiency. It focuses on delivering high-quality healthcare solutions through continuous innovation in pharmaceutical manufacturing and formulation technology.

Recent filings

Filing Released Lang Actions
董事、监事换届公告
Board/Management Information Classification · 100% confidence The document is an announcement regarding the change of the company's board of directors and supervisory board members. It details the nomination and election of new directors and supervisors, their qualifications, and the compliance with relevant laws and company regulations. There is no financial data, earnings information, or report publication mentioned. The content focuses on management and board changes, which fits the category of Board/Management Information (MANG). The document length is under 5,000 characters and is a direct announcement, not a report publication or certification. Therefore, the appropriate classification is MANG.
2024-07-28 Chinese
独立董事提名人声明与承诺（程谋、石美金、肖永欢）
Board/Management Information Classification · 95% confidence The document is a nomination statement and commitment declaration for independent director candidates of Jiangxi Xinganjiang Pharmaceutical Co., Ltd. It details the qualifications, independence criteria, and legal compliance of the nominees. There are no financial statements, earnings data, or report attachments. The content focuses on board/management information, specifically the nomination of independent directors. The document length is 2780 characters, which is relatively short and consistent with an announcement rather than a full report. Therefore, the appropriate classification is Board/Management Information (MANG).
2024-07-28 Chinese
独立董事候选人声明与承诺（肖永欢）
Board/Management Information Classification · 95% confidence The document is a declaration and commitment statement by an independent director candidate for a company's board. It details the candidate's qualifications, compliance with regulatory requirements, and independence criteria. There are no financial statements, earnings data, or report attachments. The document is a formal announcement related to board/management information, specifically about a director candidate's declaration and commitment. Therefore, it fits best under Board/Management Information (MANG). The document length is short and it is not an announcement of a report publication or a certification letter, so it is not RPA or RNS.
2024-07-28 Chinese
独立董事专门会议关于第二届董事会第三十二次会议相关事项的审查意见
Board/Management Information Classification · 95% confidence The document is a formal announcement from the independent directors of Jiangxi Xinganjiang Pharmaceutical Co., Ltd. regarding their review opinions on matters related to the 32nd meeting of the second board of directors, specifically about the nomination and election of the third board of directors. It discusses compliance with relevant laws and regulations, qualifications of director candidates, and the independent directors' agreement to submit these proposals to the board. There is no financial data, earnings information, or report publication mentioned. The content focuses on board/management matters, specifically board nominations and approvals. The document length is short (1084 characters), and it is not a report or announcement of a report publication but a governance-related announcement. Therefore, the most appropriate classification is Board/Management Information (MANG).
2024-07-28 Chinese
2024年第二次职工代表大会会议决议公告
Board/Management Information Classification · 95% confidence The document is a meeting resolution announcement from Jiangxi Xinganjiang Pharmaceutical Co., Ltd. regarding the election of a new employee representative supervisor at the company's second employee representative meeting in 2024. It includes details about the meeting date, attendance, voting results, and compliance with company law and articles of association. There is no financial data, no mention of annual or interim reports, no audit information, no earnings release, no capital or financing update, and no regulatory certification. The document is an official announcement of a board/management related decision (election of a supervisory board member). Therefore, it fits best under Board/Management Information (MANG). The document length is short and it is not a report publication announcement or a regulatory filing. Confidence is high due to clear content and context.
2024-07-28 Chinese
独立董事候选人声明与承诺（程谋）
Board/Management Information Classification · 95% confidence The document is a declaration and commitment statement by an independent director candidate for a company's board. It details the candidate's qualifications, independence criteria, and compliance with relevant laws and regulations. There is no financial data, no report of financial results, no voting results, no management changes, and no mention of any report publication. The document is a formal announcement related to board/management information, specifically about a director candidate's declaration and commitment. Therefore, it fits best under Board/Management Information (MANG). The document length is short and focused on a single candidate's statement, confirming it is not a full report or financial filing.
2024-07-28 Chinese

Browse filings by year

4 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.